A detailed history of Tcg Crossover Management, LLC transactions in Soleno Therapeutics Inc stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 550,000 shares of SLNO stock, worth $27.4 Million. This represents 3.36% of its overall portfolio holdings.

Number of Shares
550,000
Previous 550,000 -0.0%
Holding current value
$27.4 Million
Previous $23.5 Million 4.67%
% of portfolio
3.36%
Previous 2.48%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$36.04 - $52.35 $19.8 Million - $28.8 Million
550,000 New
550,000 $23.5 Million

Others Institutions Holding SLNO

# of Institutions
1
Shares Held
550K
Call Options Held
0
Put Options Held
0

About SOLENO THERAPEUTICS INC


  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $403M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Tcg Crossover Management, LLC Portfolio

Follow Tcg Crossover Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Crossover Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Crossover Management, LLC with notifications on news.